• Title/Summary/Keyword: 백신항체가

Search Result 166, Processing Time 0.031 seconds

Sandwich ELISA 방법을 이용한 숙주유래 단백질의 검출

  • 성혜윤;김창민;민홍기;용군호
    • Proceedings of the Korean Society of Applied Pharmacology
    • /
    • 1994.04a
    • /
    • pp.254-254
    • /
    • 1994
  • 현재 국내에서 시판되고 있는 생물공학 의약품매 혼입될수 있는 숙주유래 단백질을 검출하기 위하여 숙주계로 사용되고 있는 Saccaromyces cerevisiae KCTC 1720과 Escherichis coli k12의 total protein을 분리 정제하여 토끼와 guinea pig으로부터 total protein 항체를 얻었다. 이때 토끼항체의 단백질 농도는 yeast의 경우에 4.05mg/m1, E. coli의 경우에 7.14mg/m1이었고, guinea pig의 단백질농도는 yeasat의 경우에 1.90mg/m1이었고 E. coli의 경우에 7.17mg/m1이었다. S. cerevisiae와 E. coli를 숙주로 하여 생산된 생물공학 의약품의 숙주유래 단백질을 검출하기 위하여 guinea pig항체를 96 well microptate에 흡착시키고 검체와 토끼항체의 순으로 microplate에 첨가하는 방법인 sandwich ELISA방법올 사용하였다. 이 방법을 생물공학 의약품의 숙주유래 단백질 검출에 적용한 결과 사람 성장 호르몬의 경우에는 5ng/vial 이하로 검출되었다. 또한 생물학적 제제 생물공학 제품의 경우에는, B형 간염백신제재와 인터페론 감마는 1ng/vial 이하로 검출되었고 인터페론 알파의 경우에는 25ng/vial이하로 검출되었다. 또한 이 방법은 현재 개발되어 시판되고 있는 생물공학 의약품 내에 혼입된 숙주유래 단백질을 검출하는데 쓰일 것이다.

  • PDF

Serological Monitoring of Major Infectious Diseases in the Domestic Layers (국내 산란계의 주요 전염성 질병에 대한 혈청학적 모니터링)

  • Min, Bong Chul;Dam, Lai Van;Kim, Kang San;Kim, Tae Sik;Son, Joo Sung;Mo, In Pil
    • Korean Journal of Poultry Science
    • /
    • v.46 no.4
    • /
    • pp.235-247
    • /
    • 2019
  • Serological monitoring has been conducted worldwide for early diagnosis of disease and monitoring of immune status in poultry. This study was conducted to evaluate the immune status of layers with sera submitted to the Avian Disease Laboratory, Chungbuk National University from 2015 to 2017. The test results were analyzed by the time submitted and by the age of the chicks. Low pathogenic avian influenza (LPAI) showed a low positive rate of antibody compared with those of Newcastle disease, indicating that domestic vaccination against LPAI was not sufficient. The antibody profile of infectious bronchitis (IB) depicted high level of titer and a low tendency of CV as compared to the uninfected control flocks, which indicated that most layer farms have been exposed to the field IB virus. In case of avian metapneumovirus infection (aMPV) and Mycoplasma synoviae (MS), since the introduction of the vaccine in 2011 and 2017, respectively, the positive rate and the titer level were higher than those in pevious times. No significant difference in the changes of seasonal result was observed, indicating proper vaccination and improvement in biosecurity and management.

Comparison of Efficacy of Newcastle Disease Virus $B_1$ Vaccine by Different Administration .Methods in Commercial Layer Chickens (백신접종 방법에 따른 뉴캣슬병 $B_1$생독백신의 효능비교)

  • 정만호;최정옥;강춘원;노용기
    • Korean Journal of Poultry Science
    • /
    • v.17 no.3
    • /
    • pp.225-232
    • /
    • 1990
  • The immune responses of commercial layer chickens against Newcastle disease (ND) were compared among different administration methods and times of vaccination during 4 weeks of age. A total of 372 day-old chickens were devided into 4 groups of 93 birds each. Each of 3 groups was received a commercially available B$_1$ live vaccine via drinking water, eye instillation or spray method at one, 14 and 28 days of age. One group was used as an unvaccinated control. At two and 4 weeks after each time of vaccination, 15 birds from each group were challenged with virulent ND virus at the dose of 10$^{5}$ EID$_{50}$ per bird to examine the pretection rate. Ten to 15 birds from each group were bled at two weeks intervals from day old to 8 weeks of age to determine hemagglutination inhibition antibody titer. The protection rate was generally low regardless of the times of vaccination although two or more times vaccination gave higher protection than once vaccination. The low protection was considered due to low titer of the vaccine used since the vaccine titer was less than 10$^{2.5}$ EID$_{50}$ per bird. Spray method gave better protection compared to eye instillation of drinking water method which resulted in lowest response. When birds were challenged majority showed clinical signs on ND between 3 and 6 days after challenge. Death occured one or two days after onset of symptoms. Major clinical signs observed were depression (96%), drowsy(90%), anorexia (84%), diarrhoea (29%), difficult breath (15%) and torticollis (10%). Hemorrhagic lesions on post mortem were seen in duodenum (51%), trachea(36%), illeum (13%), ceacal tonsil (11%), proventriculus (10%) and some other organs. When birds were challenged majority showed clinical signs on ND between 3 and 6 days after challenge. Death occured one or two days after onset of symptoms. Major clinical signs observed were depression (96%), drowsy(90%), anorexia (84%), diarrhoea (29%), difficult breath (15%) and torticollis (10%). Hemorrhagic lesions on post mortem were seen in duodenum (51%), trachea(35%), illeum (13%), ceacal tonsil (11%), proventriculus (10%) and some other organs.

  • PDF

The efficacy and influence on growth of olive flounder Paralichthys olivaceus vaccinated against Edwardsiella tarda and Streptococcus iniae (넙치, Paralichthys olivaceus에 투여된 Edwardsiella tarda와 Streptococcus iniae에 대한 혼합백신의 예방효과와 성장에 미치는 영향)

  • Kim, Myoung-Sug;Kim, Kyoung-Duck;Kim, Kang-Woong;Park, Myoung-Ae;Kim, Jin-Woo
    • Journal of fish pathology
    • /
    • v.22 no.3
    • /
    • pp.327-334
    • /
    • 2009
  • This study was performed to verify the efficacy and safety of vaccine mixed formalin killed Edwardsiella tarda and formalin killed Streptococcus iniae in olive flounder Paralichthys olivaceus. Sera were obtained from each group at 2, 4, 6 and 8 weeks after vaccination and agglutination titers to E. tarda and S. iniae were determined using the microtiter method. Three weeks after vaccination, the fish challenged by intraperitoneal injection of E. tarda or S. iniae and immunization resulted in a relative percentage survival (RPS) of above 81.0-92.8%. Neither the groups vaccinated nor control groups resulted in significantly reduced weight gain 140 days post-vaccination, but differences between the groups vaccinated and control groups were found at the early days post-vaccination. This results suggest that it is possible to prevent edwardsiellosis and streptococosis after a vaccination without affecting growth of olive flounder.

Development of Infectious Bronchitis Virus (IBV) ELISA Kit for Detection of Antibodies against Nephropathogenic IBV Vaccine (국내회사와 다국적기업 제조 ELISA 키트의 전염성 기관지염 백신에 따른 항체 검출능 비교)

  • Kim, Kyu-Jik;Kim, Jun-Young;Youn, Ha-Na;Ju, Hyo-Sun;Lee, Da-Yeah;Song, Chang-Seon
    • Korean Journal of Poultry Science
    • /
    • v.45 no.1
    • /
    • pp.17-28
    • /
    • 2018
  • Infectious bronchitis virus (IBV) is an economically important disease in the poultry industry worldwide. This disease commonly manifests respiratory signs, poor egg quality, and decline in egg production. Since IBV is a RNA virus, the emergence of new variant strains is continuously reported and the immunization of susceptible chickens with only one antigenic type of the virus has been shown to induce partial or no protection against other unrelated types. Therefore, it is difficult to diagnose IBV due to variants serotypes. In this study, we collected serum from various ages of Broiler GP (Grandparent) to Layer CC (Commercial chick) and performed detectability comparison test between domestic company and multinational company manufacturing ELISA kit. Results of this experiment suggest that domestic company manufacturing ELISA kit is more sensitive to infectious bronchitis antibody than that of the multinational company. Our findings also suggest that antibody's change trends after infectious bronchitis vaccination. Thus, the use of appropriate kit for domestic situations is important.

The Immunogenicity and Safety Study of 47 Passaged Oka Strain Live Attenuated Varicella Vaccine in Healthy Children (건강한 소아에서의 47계대 Oka주 수두약독화 생백신의 면역원성 및 안전성에 관한 연구)

  • Kang, Jin Han;Kim, Jong Hyun;Suh, Byung Kyu
    • Pediatric Infection and Vaccine
    • /
    • v.4 no.2
    • /
    • pp.257-264
    • /
    • 1997
  • Purpose: We performed this study to find out short period humoral immunogenicity and safety of 47 passaged Oka strain live attenuated varicella vaccine(1,400PFU) in 12 months to 15 years aged healthy children. Methods: Ninety nine healthy chidren, who have no histories of varicella vaccination, recent chicken pox illness and contact, allergy to other vaccines and underlying severe diseases, were involved in this study from April 1997 to August 1997. 5ml blood were collected before vaccination and after vaccination from all vaccinees to measure varicella membrane antibody by FAMA, and varicella IgG antibody by EIA. And immediate reactions within 30 minutes after vaccination, local and systemic reactions within 3 days after vaccination and vaccine induced systemic illness during 6 weeks postvaccination period were observed in all vaccinees to identify side effects of study vaccine. Results: 1) 49 seronegative and 50 seropositive vaccinees were identified in both prevaccination serologic tests. 2) Serologic responses after vaccination measured by the FAMA in seronegative group showed that the mean GMT level revealed 64.0, and seroconversion rate was 97.9%. And serologic responses after vaccination measured by the FAMA in seropositive group showed that the mean GMT level(242.2) was markedly elevated comparing with the mean GMT level(9.2) of pre vaccination. 3) The results of EIA in seronegative group revealed that postvaccination mean GMT was 435.2(prevaccination GMT; 78.7), and 100% seroconversion rate. Also, the results of EIA in seropositve group showed that the mean GMT level(769.9) of postvaccination was almostly two fold hihger than the mean GMT level(419.7) of prevaccination. 4) Observed local reactions like injection sites redness, pain, hardness and itching sense were mild and disappeared within 3 days, also shorterm systemic reactions like irritability, lethargy, poor appetites and rash were not remarkable. And there were no remarkable side effects due to vaccine during study period in all vaccinees. Conclusion: We confirmed that 47 paasaged Oka strain live attenuated varicella vaccine has high shorterm humoral immunogenicity and safety. However, we need more detail and longterm humoral and cell mediated immunogenicity studies of this vaccine including clinical field trials.

  • PDF

Development of Transgenic Carrot Oral Vaccine to Protect against Diarrhea of Piglets (자돈 설사병 방지를 위한 경구백신용 형질전환 당근 개발)

  • 이영선;황철호
    • Journal of Plant Biotechnology
    • /
    • v.29 no.4
    • /
    • pp.287-293
    • /
    • 2002
  • We are trying to develop a transgenic carrot with aims of production and delivery of oral vaccine against microbial enteropathogen using a K88ac pilin gene. A K88ac antigen (pilin) gene was isolated by PCR from the K88ac genomic DNA. The pilin gene was constructed in pGA748 and introduced via Agrobacterium tumefaciens to the explants of carrot hypocotyl and then 494 transgenic lines were established. The amounts of the K88ac antigen produced in each of the cell lines were determined by western and two elite cell lines (M1-17, Y14-1) were selected based on higher levels of expression of the antigens as well as rate of cell growth and efficiency of embryogenesis. In order to test an immunization induced by oral administration of the transgenic carrot, serum of the mice fed with the carrot vaccine were tested in ELISA. It tumed out that the mice fed with 3 g of transgenic carrot showed a similar level of antibody compared to those applied with 10 $\mu\textrm{g}$ of the purified recombinant pilin protein. Besides, various clinical responses were measured after challenging with ETEC K88ac strain to the piglets experiencing an oral immunization with the transgenic carrot. The piglets fed with carrot vaccine showed a lower level of diarrhea in fecal score compared to those fed with non-transgenic carrot. A higher level of increase in weight of the piglets fed with the transgenic carrot vaccine was observed comparing to those fed with non-transgenic carrot as control.

Tow-Year Follow-up Study for Clinical Feature and Immunity of The Children, Vaccinated by 47 Passaged Oka Strain Live Attenuated Varicella Vaccine (47계대 Oka주 약독화 생백신 접종 후 2년간 임상 및 면역성의 추적 연구)

  • Kang, Jin Han;Kim, Jong Hyun;Hur, Jae Kyun;Woo, Koo
    • Pediatric Infection and Vaccine
    • /
    • v.7 no.1
    • /
    • pp.129-135
    • /
    • 2000
  • Purpose : We previously reported the short-term immunogenecity and safety of 47 passaged Oka strain live attenuated varicella vaccine in healthy children in 1997. Now, we conducted this two-year follow-up study to confirm the maintenance of immunity, the occurrence of natural varicella infection and the activation of vaccine induced latent infection on the same vaccine. Methods : 99 children who had been immunized by 47 passaged Oka strain live attenuated varicella vaccine in 1997 were followed up by questionnaire, and 46 children out of study group were followed up serologically. They were asked to report any instance of varicella or herpes zoster since they had been immunized. If there was any evidence of varicella or herpes zoster, they should be clinically or serologically confirmed by doctor. Also, those patients' parents were asked to report any instance of varicella or herpes zoster in their family, playmate, kindergarten, school, or other settings. The immunity to VZV was confirmed by EIA and FAMA test. Results : 6 recipients developed breakthrough varicella after exposure to VZV in family, kindergarten and school during follow-up period. However, clinical features of those patients were very mild and self limited without therapy. And none of the recipients developed herpes zoster during this observation period. The results of EIA test showed that study subjects were all seropositive except one, and the antibody titers and GMT of FAMA test were seropositively maintained in all subjects. Statistically, the antibody titers of EIA and FAMA test confirmed two years after vaccination were higher than those results confirmed one month after vaccination. Conclusion : Our study results suggest that the immunity of 47 passaged Oka strain live attenuated varicella is well maintained until 2 years later after vaccination, and mild natural infection after exposure to VZV can be occurred with low rate. There were not developing zoster in study vaccine after vaccination for two-years.

  • PDF

Sero-epidemiology of the major swine infectious disease in Cheju (제주지역에 대한 돼지 주요 전염병의 혈청학적 역학조사)

  • Lyoo, Young-soo;Park, Choi-kyu;Kim, Lo-mi;Lee, Chang-hee;Choi, Sang-ho;Kim, Sung-il;Bae, Jong-hee
    • Korean Journal of Veterinary Research
    • /
    • v.37 no.4
    • /
    • pp.765-772
    • /
    • 1997
  • 제주지역 돼지에서 각종 전염성 질병 원인체에 대한 항체를 조사하여 그간 전염성 병원체에 대한 역학조사가 미진하였던 부분을 보완하여 질병의 분포를 파악하고자 1995년부터 1996년에 걸쳐 제주도 전역에서 돼지의 혈청을 채취하여 각종 병원체에 대한 항체 분포율을 조사하였다. 본 연구에서 검사한 돼지 혈청 시료에서는 돼지 오제스키병 바이러스에 대한 항체는 전혀 검출되지 않았다. 돼지 콜레라바이러스에 대한 항체는 기대 수준 이하로 낮아 백신접종이 원활히 수행되고 있지 않음을 시사하였으며 특히 농장에 따라 항체 보유돈과 항체 음성돈이 혼재하는 농장과 항체가 전혀 검출되지 않는 농장 등 돼지 콜레라 방역의 사각지대가 존재할 가능성이 있음을 보여주었다. 유 사산 원인체인 돼지 파보바이러스 및 뇌심근염에 대한 항체가가 다양하게 나타나 일부 문제가 있을 것으로 사료되었다. 돼지 생식기호흡기증후군(PRRS) 바이러스에 대한 항체 분포율은 내륙 보다 다소 낮게 나타났고, 돼지 influenza virus, 위축성 비염, 흉막 폐염 등 각종 세균성 질환에 대한 항체수준도 다양하게 나타났다. 본 혈청학적인 연구결과는 제주지역에서의 양돈방역 정책수립 및 질병방제의 기초자료로 유용하게 이용될 것으로 사료된다.

  • PDF

구제역 백신의 특성과 올바른 사용방법

  • Park, Choe-Gyu
    • Journal of the korean veterinary medical association
    • /
    • v.48 no.3
    • /
    • pp.144-149
    • /
    • 2012
  • 최근의 구제역 발생은 발생규모와 확산속도 면에서 과거에 우리가 경험했던 구제역과는 확연하게 달랐다. 수 많은 가축을 매몰하고, 그 동안의 모든 방역경험을 다 쏟아 부었지만 구제역의 확산속도는 수그러들지 않았다. 그러한 상황에서 더 이상의 가축의 희생을 줄이고, 축산업 자체의 붕괴를 막기 위하여 전국적인 긴급 예방접종은 불가피한 선택이었다고 생각한다. 다행스럽게도 전국적인 긴급 예방접종 이후 단기간에 구제역의 발생은 급격하게 감소되었고, 현재는 임상증상을 나타내는 발생은 거의 자취를 감추었다. 그러나 발생 감소와는 상관없이 앞으로도 당분간은 정기적인 예방접종이 지속될 전망이다. 첫째, 내적으로는 아직도 바이러스 전파원이 될 수 있는 잠복감염 가축(즉 캐리어)이 남아있을 수 있기 때문이며, 둘째, 외적으로는 우리나라 주변국에서 구제역의 발생이 지속되고 있는 상황에서 언제라도 새로운 구제역 바이러스가 국내에 유입될 수 있기 때문이다. 따라서 당분간은 철저한 예방접종을 통하여 구제역이 발병, 확산되지 않도록 하여야 한다. 구제역과 같은 전염병의 확산을 막기 위해서는 감수성이 있는 가축집단에 일정수준의 면역이 유지되어야 하는데, 질병 역학자들은 집단 내 80% 이상의 개체가 면역이 되어야 한다고 한다. 그런데 구제역 예방접종 이후 소는 항체 형성이 잘되는 반면에 돼지는 항체 형성률이 낮게 나타난다는 양돈농가의 호소가 이어지고 있다. 이에 따라 방역당국과 양돈협회에서는 올바른 예방접종 요령에 대한 홍보자료를 작성하여 농가에 배포하고, 전문수의사를 동원한 교육을 계획하고 있다. 본고에서는 구제역 예방접종의 효과를 높이고, 접종 부작용을 줄이기 위하여 어떻게 백신을 관리하고 접종해야 하는지 상세하게 알아보고자 한다.

  • PDF